Lineage Cell Therapeutics (LCTX) Other Non-Current Liabilities (2010 - 2026)
Lineage Cell Therapeutics' Other Non-Current Liabilities was $24.7 million in Q2 2026, up 31.4% from $18.8 million a year earlier but down 27.7% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Liabilities at Lineage Cell Therapeutics came in at $43.91 million, up 612.6% from FY2024.
- Other Non-Current Liabilities shows a four-year compound annual growth rate of 518.5% (FY2021 to FY2025).
- In earlier years, Other Non-Current Liabilities was $6.16 million in FY2024, $2,000 in FY2022 (-93.3%) and $30,000 in FY2021.
- Quarterly Other Non-Current Liabilities has moved between $2,000 (Q4 2022) and $45.17 million (Q3 2025) over five years.
- Compared with a year earlier, Other Non-Current Liabilities has increased for three straight quarters.
- Per Business Quant data, LCTX's Other Non-Current Liabilities in the three quarters before Q2 2026 was $34.14 million (Q1 2026), $43.91 million (Q4 2025) and $45.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn |
| 10 | Lineage Cell Therapeutics | 248.35 Mn | 47.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.70 Mn |
| Mar 31, 2026 | 34.14 Mn |
| Dec 31, 2025 | 43.91 Mn |
| Sep 30, 2025 | 45.17 Mn |
| Jun 30, 2025 | 18.80 Mn |
| Mar 31, 2025 | 6.06 Mn |
| Dec 31, 2024 | 6.16 Mn |
| Dec 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Dec 31, 2018 | 244,000.00 |
| Sep 30, 2018 | 238,000.00 |
| Jun 30, 2018 | 189,000.00 |
| Mar 31, 2018 | 114,000.00 |
| Dec 31, 2017 | 105,000.00 |
| Sep 30, 2017 | 645,000.00 |
| Jun 30, 2017 | 88,000.00 |
| Mar 31, 2017 | 75,000.00 |
| Dec 31, 2016 | 50,000.00 |
| Sep 30, 2016 | 46,000.00 |
| Jun 30, 2016 | 28,000.00 |
API Access
Lineage Cell Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();